Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2020-06-11

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2020-05-08

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-05-08

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-05-05

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-04-20

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-04-10

View Filing

DEF 14A - Other definitive proxy statements

Form Type: DEF 14A

Filing Date: 2020-03-20

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2020-03-20

View Filing

10-Q - Quarterly report [Sections 13 or 15(d)]

Form Type: 10-Q

Filing Date: 2020-03-13

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2020-03-13

View Filing